Related Experiment Video
Updated: Jul 24, 2025

Author Spotlight: Exploring Huotan Jiedu Tongluo Decoction as an Antihypertensive Drug
Published on: May 17, 2024
Association between hypertension and clinical outcomes in COVID-19 patients: a case-controlled study
Fatemeh Aslanbeigi1, Habiballah Rahimi2, Adeleh Malekipour3
1School of Medicine, Kashan University of Medical Sciences.
Insights
Hypertension is linked to worse outcomes and increased mortality in coronavirus disease 2019 (COVID-19) patients. Managing blood pressure is crucial for COVID-19 patient care and improving prognosis.
Area of Science:
- Medicine
- Public Health
- Infectious Diseases
Background:
- The COVID-19 pandemic, caused by SARS-CoV-2, presents a significant global health challenge.
- Understanding clinical differences in COVID-19 patients with and without hypertension is vital for effective management.
Purpose of the Study:
- To compare clinical symptoms and physical findings in hypertensive versus nonhypertensive patients with COVID-19.
- To assess the impact of hypertension on COVID-19 outcomes and mortality.
Main Methods:
- A retrospective observational case-control study involving 280 laboratory-confirmed COVID-19 patients.
- Data on demographics, clinical findings, and comorbidities were extracted from a hospital registry.
Main Results:
- No significant differences in common symptoms like fever or cough were observed between hypertensive and nonhypertensive groups.
- COVID-19 mortality was significantly higher in patients with hypertension compared to those without.
- Older patients exhibited a higher prevalence of underlying diseases.
Conclusions:
- Hypertension is associated with poorer prognosis and increased mortality in COVID-19 patients.
- Optimizing blood pressure management is essential for COVID-19 patient care.
- Early intervention and education for elderly patients with hypertension and comorbidities are important.
Abstract:
The outbreak of coronavirus disease 2019 (COVID-19), which was originated from a severe acute respiratory syndrome-coronavirus-2 (SARS-COV-2) infection, has become an international public health emergency. The aim of this study was to assess the clinical symptoms and physical findings in both hypertensive and nonhypertensive patients infected with COVID-19.
Methods:
A retrospective observational case-control study with diagnosis of COVID-19 by laboratory-confirmed test was conducted on 280 consecutive unselected patients. This was a single-center study. The demographics, laboratory, and clinical findings data were extracted from the hospital registry database.
Results:
Of our 280 patients in the study, there were 149 men (53%) and 138 (50%) were older than 60 years (mean=67.75), and also 50 in-hospital deaths occurred (mortality rate, 17%). Total 19(6.9%) were taking opioid, and smoking. There were no significant differences in the rate of fever, cough, sputum production, gastrointestinal symptoms, myalgia, and headache in the both hypertensive and nonhypertensive groups. The prevalence of underlying diseases was significantly higher in older patients in comparison with younger ones (P=0<0.05), COVID-19 mortality was noticed to be higher among hypertensive patients as compared with nonhypertensive patients (P=0<0.05).
Conclusion:
Hypertension is associated with a poor prognosis and higher mortality among COVID-19 patients. Optimizing blood pressure is essential during the management of COVID-19. Our research implies the importance of early care and education of old patient with hypertension and other comorbidities.
More Related Videos
Related Concept Videos
Hypertension III: Clinical Manifestations and Diagnostic Studies
Hypertension II: Pathophysiology
Hypertension and Regulation of Blood Pressure
Hypertension I: Introduction
Factors affecting Blood pressure
Physiological Factors:
Measurement of Blood Pressure

